Skip to main content

Anatomy and the Complications Associated with Liver Diseases!

 LIVER AND THE COMPLICATIONS ASSOCIATED WITH THE PROGRESSION OF DISEASE!


Liver:

  • The liver weighs up to 1.5kg in adults and is the 2nd largest organ in the body. Hepatocytes are the functioning unit of liver.
  • Impairment of liver may lead to:

  1. Acute liver diseases
  2. Chronic liver diseases
  3. Liver cirrhosis



Acute Liver Disease (ALD):

  • ALD is a self-limiting episode of hepatocyte damage which in most cases spontaneously without clinical sequelae, but acute liver failure (ALF) may develop. This is a rare condition in which there is a rapid deterioration in liver function with associated encephalopathy and coagulopathy.
  • ALF carries significant morbidity and mortality and may require emergency liver transplant.


Chronic Liver Disease (CLD):

  • CLD occurs when the longstanding cell damage causes permanent structural changes within the liver, with the loss of normal liver structure and functions.
  • In many cases, this may lead to cirrhosis where fibrosis sears divide the liver cells into areas of regenerative tissues called Nodules. It is usually irreversible but therapeutic interventions in Hepatitis B Virus (HBV)and Hepatitis C Virus (HCV), and hemochromatosis has demonstrated the ability to reverse cirrhosis.
  • CLD can progress to:

  1. Liver failure
  2. Portal hypertension
  3. Hepatocellular carcinoma


Causes of Liver Disease/ Etiology:

  1. Viral infections
  2. Hepatitis
  3. Alcohol
  4. Immune disease
  5. Vascular abnormalities
  6. Genetic and metabolic disorders


Clinical Features of Acute Infection:

Non-specific features include;

  1. Headache
  2. Nausea
  3. Development of jaundice within 2 weeks
  4. Vomiting
  5. Diarrhea
  6. Dark urine
  7. Pale stools
  8. Myalgia
  9. Arthralgia
  10. Anorexia
  11. Abdominal discomfort

Physical signs include;

  1. Liver tenderness
  2. Mild splenomegaly

  • Symptoms last longer than 3-6 weeks


Complications:

  1. Acute Liver failure (ALF)
  2. Chronic liver disease (CLD)
  3. Liver cirrhosis (HBV &HCV)
  4. Cholestatic hepatitis (HAV)
  5. Aplastic anemia


Investigations:

  1. Liver Function Test: Low serum transaminase, Plasma bilirubin exceeds twice of normal.
  2. Serological test: Confirms the cause of infection.


General Management:

  • Most patients do not need hospital care.
  • Drugs metabolized in liver (sedatives, narcotics) should be stopped.
  • Avoid alcohol consumption.
  • No specific dietary modification required.
  • Increase fluid intake.


Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD)
Post a Comment
Read more

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-50mg/dL and A1c level
Post a Comment
Read more

GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)!

MANAGEMENT OF GASTRO-ESOPHAGEAL REFLUX DISEASE  "GERD refers to the endoscopically determined esophagitis or endoscopy-negative reflux disease" . "GERD is the term used to describe any symptomatic clinical condition or histopathological alteration resulting from episodes of reflux of acid, pepsin and occasionally, bile into the esophagus from the stomach". Patients with uninvestigated "reflux-like" symptoms should be managed as patients with uninvestigated dyspepsia. There is currently no evidence that H.pylori should be investigated in patients with GERD. Symptoms: Heartburn is the characteristic symptom of GERD. Acid regurgitation Dysphagia Belching Upper abdominal discomfort Bloating and postprandial fullness Chest pain Hoarseness Cough Complications include: Esophageal ulceration Formation of specialized columnar-lined esophagus at the gastro-esophageal junction known as Barretts Esophagus . Mechanism of Acid Reflux: The mechanism of acid reflux is mu
Post a Comment
Read more